Schedule 13G ownership disclosure

IONIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 462222100

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,415,156
Percent of class
6.9400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001088875-17-000015
Form type
SC 13G
Filer
BAILLIE GIFFORD & CO
CIK
CIK 1088875
Filed
Jan 27, 2017
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub